Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Provella
- Development stage
- Unknown
- Lead developer
- Vertical Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Provella is a probiotic dietary supplement developed by Vertical Pharmaceuticals specifically tailored for women's health. It contains a proprietary blend of six probiotic strains, including *Lactobacillus acidophilus* (La-14), *Lactobacillus rhamnosus* (HN001), *Lactobacillus gasseri* (Lg-36), *Bifidobacterium lactis* (Bi-07), *Bifidobacterium lactis* (Bl-04), and *Lactobacillus plantarum* (Lp-115). The supplement is designed to support digestive, vaginal, and immune health by restoring and maintaining a healthy balance of microflora, which can be disrupted by factors such as diet, stress, or the use of antibiotics. It is marketed as a once-daily oral capsule.
- Brand names
- Provella
- Other names
- Provella
Beyond the preview
Go deeper on Provella.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Provella.